Our patented Sound Bites platform offers a convenient, unbiased way for oncologists to stay up-to-date.

Critical, on-demand information right at your fingertips when and where it is most convenient for you. Subscribe to receive 60 – 90 second video clips from thought leaders via text message.

Credible oncology updates at your fingertips.

Free. No ads. No bias.

Enter our monthly iPad Giveaway!
Earn an entry each time you watch a full Sound Bites video. It's that easy.

Browse Clinical Trial Updates

All
Breast Cancer
CNS Malignancies
Conference Updates
Diagnostics
GI Cancers
GU Cancers
GYN Oncology
Hematologic Malignancies
Lung Cancer
Skin Cancer
Dr. Joe Mendez reviews the watch and wait vorasidenib patient profile in low-grade gliomas (Video 3/3)

Dr. Joe Mendez reviews the watch and wait vorasidenib patient profile in low-grade gliomas (Video 3/3)

INDIGO surveillance profile

Joe Mendez, MD
CNS Malignancies
Conference Updates
+1 more
Dr. Ghaith Abu-Zeinah reviews the risks and threats in essential thrombocythemia (Video 2/3)

Dr. Ghaith Abu-Zeinah reviews the risks and threats in essential thrombocythemia (Video 2/3)

Risk and Threats in ET

Hematologic Malignancies
Dr. Laura van ‘t Veer describes the residual cancer burden with ctDNA in breast cancer (Video 3/3)

Dr. Laura van ‘t Veer describes the residual cancer burden with ctDNA in breast cancer (Video 3/3)

ctDNA and RCB

Breast Cancer
Dr. Sandip Patel reviews the benefit of adding local consolidative treatment to 1L osimertinib in EGFRm mNSCLC. (Video 2/3)

Dr. Sandip Patel reviews the benefit of adding local consolidative treatment to 1L osimertinib in EGFRm mNSCLC. (Video 2/3)

OsiContinuation NORTHSTAR

Lung Cancer
Dr. Ghaith Abu-Zeinah explores why essential thrombocythemia matters and the current unmet needs in patient care (Video 1/3)

Dr. Ghaith Abu-Zeinah explores why essential thrombocythemia matters and the current unmet needs in patient care (Video 1/3)

Why ET Matters: The Unmet Need

Hematologic Malignancies
Dr. Joshua Richter reviews the safety profile and AE management of MeziKd (Video 2/3)

Dr. Joshua Richter reviews the safety profile and AE management of MeziKd (Video 2/3)

MeziKd Safety Profile

Hematologic Malignancies

Why subscribe?

  • Get one-minute, non-promotional, educational videos from distinguished thought leaders
  • Tailored to topics you select
    • Breast Cancer
    • Lung Cancer
    • Gastrointestinal Cancers
    • Genitourinary Cancers
    • Gynecologic Cancers
    • Hemotologic Malignancies
    • Conference updates and more
  • No spam. No ads. No apps to download.
  • Always free and you can opt-out anytime if you feel this isn’t for you.

Fill out the form above to subscribe!

Our patented Sound Bites platform offers a convenient, unbiased way for oncologists to stay up-to-date.

Critical, on-demand information right at your fingertips when and where it is most convenient for you. Subscribe to receive 60 – 90 second video clips from thought leaders via text message.

Intended for USA healthcare providers only.

If your institution is not listed, please input the Institution / Company name in the field below.

By clicking Subscribe, I agree that I have read and understand IDEOlogy Health’s Privacy Policy and Terms and Conditions and further agree to receive information from IDEOlogy Health and its companies

ideology-health
Inc. 5000

IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America

© 2026 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.